Intracoastal holds 4.99% Silexion Therapeutics stake

Rhea-AI Filing Summary

Silexion Therapeutics Corp (SLXN) is the subject of a Schedule 13G filed by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC reporting their beneficial ownership. As of the close of business on August 18, 2026, they may be deemed to beneficially own 286,866 Ordinary Shares, including shares underlying several warrants, representing 4.99% of Silexion’s Ordinary Shares. This position reflects a Securities Purchase Agreement dated August 11, 2026 and multiple Intracoastal warrants that contain blocker provisions limiting exercises so that the Reporting Persons’ beneficial ownership does not exceed specified percentage thresholds (primarily 4.99% or 9.99%). All voting and dispositive power is reported as shared, with no sole power over the shares.

Key Figures

Beneficial ownership: 286,866 Ordinary Shares Percent of class: 4.99% Shares outstanding: 5,560,256 Ordinary Shares +5 more

8 metrics

Beneficial ownership 286,866 Ordinary Shares Shares beneficially owned by the reporting persons as of August 18, 2026

Percent of class 4.99% Reported percentage of Silexion Ordinary Shares beneficially owned

Shares outstanding 5,560,256 Ordinary Shares Silexion shares outstanding as of August 13, 2026 used for ownership calculation

Shares held outright 128,916 Ordinary Shares Ordinary Shares of Silexion held by Intracoastal as part of beneficial ownership

Intracoastal Warrant 2 included portion 86,530 Ordinary Shares Ordinary Shares issuable upon exercise of Intracoastal Warrant 2 counted in 286,866

Intracoastal Warrant 3 32,500 Ordinary Shares Ordinary Shares issuable upon exercise of Intracoastal Warrant 3, subject to blocker

Intracoastal Warrant 4 38,920 Ordinary Shares Ordinary Shares issuable upon exercise of Intracoastal Warrant 4, subject to blocker

Intracoastal Warrant 2 excluded portion 298,086 Ordinary Shares Additional shares under Intracoastal Warrant 2 excluded due to 4.99% blocker provision

Key Terms

Securities Purchase Agreement, beneficial ownership, blocker provision, Ordinary Shares, +1 more

5 terms

Securities Purchase Agreement financial

"Immediately following the execution of the Securities Purchase Agreement with the Issuer"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

beneficial ownership financial

"each of the Reporting Persons may have been deemed to have beneficial ownership of"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

blocker provision financial

"because Intracoastal Warrant 2 contains a blocker provision under which the holder"

Ordinary Shares financial

"Ordinary shares, par value $0.135 per share"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

dispositive power financial

"Shared Dispositive Power 273,866.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

What percentage of Silexion Therapeutics Corp (SLXN) does Intracoastal report owning?

The reporting group states beneficial ownership of 4.99% of Silexion’s Ordinary Shares. This corresponds to 286,866 Ordinary Shares, including shares underlying certain warrants, based on 5,560,256 Ordinary Shares outstanding as of August 13, 2026.

How many Silexion (SLXN) shares are beneficially owned by the reporting persons?

The reporting persons may be deemed to beneficially own 286,866 Ordinary Shares of Silexion. This total includes 128,916 shares held outright by Intracoastal and shares issuable upon exercise of several Intracoastal warrants, subject to blocker provisions.

What warrants on Silexion (SLXN) shares does Intracoastal Capital LLC hold?

Intracoastal holds multiple Silexion warrants, including Intracoastal Warrant 2, Intracoastal Warrant 3 and Intracoastal Warrant 4. These cover shares such as 32,500 and 38,920 Ordinary Shares and are subject to blocker provisions limiting exercisability above set ownership caps.

What are the blocker provisions mentioned in the Silexion (SLXN) Schedule 13G?

The warrants contain blocker provisions that prevent exercises which would push beneficial ownership above 4.99% or 9.99% of Silexion’s Ordinary Shares. As a result, hundreds of thousands of warrant shares are excluded from the current reported beneficial ownership.

How many Silexion (SLXN) shares are outstanding according to this Schedule 13G?

The filing cites 5,560,256 Ordinary Shares of Silexion outstanding as of August 13, 2026. This figure, plus certain issuable warrant shares, is used as the basis for calculating the reporting persons’ 4.99% beneficial ownership stake.

Who are the reporting persons in the Silexion Therapeutics Corp (SLXN) Schedule 13G?

The Schedule 13G is filed on behalf of Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC. They report shared voting and dispositive power over Silexion Ordinary Shares and related warrant positions described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:37 PM Accepted by SEC EDGAR 08/18/2026 - 05:36 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Silexion Therapeutics Corp

(Name of Issuer)

Ordinary shares, par value $0.135 per share

(Title of Class of Securities)

G1281K130

(CUSIP Number)

08/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G1281K130

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 286,866.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 273,866.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

286,866.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): G1281K130

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 286,866.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 273,866.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

286,866.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP Number(s): G1281K130

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 286,866.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 273,866.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

286,866.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Silexion Therapeutics Corp
(b)	Address of issuer's principal executive offices: 12 Abba Hillel Road, Ramat-Gan, Israel 5250606
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Ordinary shares, par value $0.135 per share
(e)	CUSIP Number(s): G1281K130
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: (i) Immediately following the execution of the Securities Purchase Agreement with the Issuer on August 11, 2026 (the "SPA") (as disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on August 13, 2026), each of the Reporting Persons may have been deemed to have beneficial ownership of 149,724 Ordinary Shares, which consisted of (i) 149,000 Ordinary Shares to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (ii) 724 Ordinary Shares issuable upon exercise of a warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA ("Intracoastal Warrant 1"), and all such Ordinary Shares represent beneficial ownership of approximately 9.99% of the Ordinary Shares, based on (1) 1,349,019 Ordinary Shares outstanding as of August 9, 2026, as reported to by the Issuer, (2) 149,000 Ordinary Shares to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (3) 724 Ordinary Shares issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 234,892 Ordinary Shares issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Ordinary Shares, (II) 384,616 Ordinary Shares issuable upon exercise of a second warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Ordinary Shares, (III) 32,500 Ordinary Shares issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 3") because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Ordinary Shares and (IV) 38,920 Ordinary Shares issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 4") because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Ordinary Shares. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 840,652 Ordinary Shares. (ii) As of the close of business on August 18, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 286,866 Ordinary Shares, which consisted of (i) 128,916 Ordinary Shares held by Intracoastal, (ii) 32,500 Ordinary Shares issuable upon exercise of Intracoastal Warrant 3 (iii) 38,920 Ordinary Shares issuable upon exercise of Intracoastal Warrant 4 and (iv) 86,530 Ordinary Shares issuable upon exercise of Intracoastal Warrant 2, and all such Ordinary Shares represent beneficial ownership of approximately 4.99% of the Ordinary Shares, based on (1) 5,560,256 Ordinary Shares outstanding as of August 13, 2026, as reported to by the Issuer, (2) 30,616 issued to Intracoastal upon exercise of Intracoastal Warrant 1 following August 13, 2026, (3) 32,500 Ordinary Shares issuable upon exercise of Intracoastal Warrant 3, (4) 38,920 Ordinary Shares issuable upon exercise of Intracoastal Warrant 4 and (5) 86,530 Ordinary Shares issuable upon exercise of Intracoastal Warrant 2. The foregoing excludes 298,086 Ordinary Shares issuable upon exercise of Intracoastal Warrant 2 because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Ordinary Shares. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 584,952 Ordinary Shares.
(b)	Percent of class: 4.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 286,866
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 273,866
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	08/18/2026

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	08/18/2026

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	08/18/2026

Exhibit Information

Exhibit 1 - Joint Filing Agreement